Downregulation of renin gene expression by interleukin-1

Hypertension

Volumn 30, Issue 2, 1997, Pages 230-235

  Petrovic, Nenad ^a   Kane, Colleen M ^a   Sigmund, Curt D ^b   Gross, Kenneth W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Hypotension; Interleukin 1; Renin; Septic; Shock; Transcription

Indexed keywords

INTERLEUKIN 1; MESSENGER RNA; RENIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE DETERMINATION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPORTER GENE; RNA ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0030791443     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.2.230     Document Type: Article

References (27)

1. Pruitt JH, Copeland EM 3rd, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflamatory response syndrome, and septic shock. Shock. 1995;3:235-251.
2. Nemunaitis J, Appelbaun FR, Lilleby K, Buhles WC, Rosenfeld C, Zeigler ZR, Shadduck RK, Singer JW, Meyer W, Buckner CD. Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood. 1994;83:3473-3479.
3. Aiura K, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits. Infect Immun. 1993; 61:3342-3350.
4. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei F-Y, Wong W, Kamen R, Seshadri T. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1994;80:401-411.
5. Sigmund CD, Okuyama K, Ingelfinger J, Jones CA, Mullins JJ, Kane C, Kim U, Wu CZ, Kenny L, Rustum Y, Dzau VJ, Gross KW. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem. 1990;265:19916-19922.
6. Sigmund CD, Jones CA, Fabian JR, Mullins JJ, Gross KW. Tissue and cell specific expression of a renin promoter-reporter gene construct in transgenic mice. Biochem Biophys Res Commun. 1990; 170:344-350.
7. Jones CA, Sigmund CD, McGowan R, Kane-Haas C, Gross KW. Temporal and spatial expression of the murine renin genes during fetal development. Mol Endocrinol. 1990;4:375-380.
8. Sigmund CD, Jones CA, Jacob H, Ingelfinger J, Kim U, Gamble D, Dzau VJ, Gross KW. Pathophysiology of vascular smooth muscle in renin promoter-T antigen transgenic mice. Am J Physiol. 1991;260: F249-F257.
9. Jones CA, Petrovic N, Novak EK, Swank RT, Sigmund CD, Gross KW. Biosynthesis of renin in mouse kidney tumor As4.1 cells. Eur J Biochem. 1997;243:181-190.
10. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW. Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem. 1996;271:22499-22505.
11. Field LJ, Philbrick WM, Howles PN, Dickinson DP, McGowan RA, Gross KW. Expression of tissue-specific Ren-1 and Ren-2 genes of mice: comparative analysis of 5′-proximal flanking regions. Mol Cell Biol. 1984;4:2321-2331.
12. In: Murray EJ, ed. Methods in Molecular Biology. Vol 7: Gene Transfer and Expression Protocols. Clifton, NJ: Humana Press; 1991:8-10.
13. Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucl Acids Res. 1987; 15:1311-1326.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248-254.
15. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982;2:1044-1051.
16. Chu WN, Baxter JD, Reudelhuber TL. A targeting sequence for dense secretory granules resides in the active renin moiety of human preprorenin. Mol Endocrinol. 1990;4:1905-1913.
17. In: Murray EJ, ed. Methods in Molecular Biology. Vol 7: Gene Transfer and Expression Protocols. Clifton, NJ: Humana Press; 1991:316-320.
18. Field LJ, McGowan RA, Dickinson DP, Gross KW. Tissue and gene specificity of mouse renin expression. Hypertension. 1984;6:597-603.
19. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore JF, Wolff SM, Burke JF, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990;161:79-84.
20. Jikihara H, Poisner AM, Handwerger S. Tumor necrosis factor-α and interleukin-1β inhibit the synthesis and release of renin from human decidual cells. J Clin Endocrinol Metab. 1995;80:195-199.
21. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994;120: 771-783.
22. Wolfe TA, Dasta JF. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother. 1995;29:36-46.
23. Hata JS, Dellinger RP. Nitric oxide inhibition in the treatment of septic shock. Crit Care Med. 1995;23:1621-1624. Editorial.
24. Van Den Berg C, Van Amsterdam JG, Bisschop A, Piet JJ, Wemer J, De Wildt DJ. Septic shock: no correlation between plasma levels of nitric oxide metabolites and hypotension or lethality. Eur J Pharmacol. 1994;270:379-382.
25. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA. 1995;92:10688-10692.
26. MacMicking JD, Nathan C, Horn G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
27. Ryding J, Heslet L, Hartvig T, Jonsson V. Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. Chest. 1995;107:201-203.